Media stories about PhotoMedex (NASDAQ:FCRE) have trended somewhat negative recently, according to Accern. Accern rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. PhotoMedex earned a media sentiment score of -0.09 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 45.0091899549729 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of PhotoMedex (NASDAQ FCRE) opened at $1.00 on Wednesday. PhotoMedex has a 1 year low of $0.70 and a 1 year high of $5.60.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.dailypolitical.com/2017/11/15/photomedex-fcre-receiving-somewhat-negative-press-coverage-analysis-finds.html.

PhotoMedex Company Profile

FC Global Realty Incorporated, formerly PhotoMedex, Inc, is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage.

Receive News & Ratings for PhotoMedex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhotoMedex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.